The clinical trials below are available in the specialty you selected.
Choose a different specialty.
Single Dose-Escalation and Multiple Dose Extension Trial of Anti-IFN-α Antibody in Subjects with Systemic Lupus Erythematosus
People with lupus are needed for a clinical research trial.
(REF# 17538)
Mechanisms of Insulin Resistance in Persons with Rheumatoid Arthritis
Mechanisms of insulin resistance in persons with rheumatoid arthritis.
(REF# 7701)
Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SBI-087 Administered to Subjects with Systemic Lupus Erythematosus
If you are between 18 and 70 years old and have been diagnosed with lupus for more than six months, you may be eligible to participate in this clinical research study.
(REF# 15533)
Page 1 of 1